摘要
卵巢性索间质肿瘤是指起源于原始性腺中性索和间质组织的一类卵巢肿瘤,其中既有良性也有恶性,常见几种有颗粒细胞瘤、卵泡膜细胞瘤、纤维瘤、良性支持-间质细胞瘤、两性母细胞瘤等等。根据ICD-10分类对肿瘤编码要求,卵巢性索间质肿瘤部位编码为D27(良性)或D39.1(交界恶性)或C56(恶性),而其形态学编码在实际工作中要依靠病理诊断甚至免疫组化来给予准确编目。免疫组化直接影响卵巢性索间质肿瘤编码的正确性,是该类疾病编码时所需参照的重要医学检查资料。通过选取6例代表性的卵巢性索间质肿瘤进行回顾性分析,探讨免疫组化对该类疾病编码的重要性,从而指导编码人员对该类疾病认识准确编码,进而提高该类疾病编码质量。
Ovarian sex cord stromal tumor is originated from primitive gonad neutral line and interstitial tissue of ovarian tumors, which has both benign and malignant, common kinds of granular cell tumor, theca cell tumor, benign fibroma, support-interstitial cell tumor, tumor the sexes and so on. Tumor according to the classification of ICD-10 code requirements, ovarian sex cord stromal tumor site code for D27（benign 36） or D39.1 border（malignant） or C56（malignant）, and its morphological coding in practice depends on pathological diagnosis even immunohistochemical to give accurate catalog. Immunohistochemistry directly affects the correctness of the coding of ovarian stromal tumors, which is an important medical examination data to refer to when coding these diseases.Through six representative cases of ovarian sex cord stromal tumor were retrospectively analyzed, immunohistoc hemical the importance of this kind of disease coding is discussed, and thus to guide coders accurate coding in cognition of the disease, and thus improve the quality of this kind of disease coding.
作者
罗争
由杨
Luo Zheng;You Yang(Beijing Maternity Hospital Affiliated to Capital Medical University,Beijing 100006,China)
出处
《中国病案》
2018年第7期21-23,共3页
Chinese Medical Record
